Yuh-Min Chen, Jacqueline Ming Liu, Teh-Ying Chou, Reury-Perng Perng, Chun-Ming Tsai and Jacqueline Whang-Peng Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy Cancer 109
Version of Record online: 9 MAR 2007 | DOI: 10.1002/cncr.22616
Gefitinib was highly effective in ethnic Chinese patients with adenocarcinoma of the lung who failed previous platinum and taxane treatment. The addition of low-dose vinorelbine every 2 weeks produced a significantly better 1-year progression-free survival rate.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field